Tri Locum Partners LP Buys Shares of 28,115 UnitedHealth Group Incorporated (NYSE:UNH)

Tri Locum Partners LP acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 28,115 shares of the healthcare conglomerate’s stock, valued at approximately $14,222,000. UnitedHealth Group accounts for 2.9% of Tri Locum Partners LP’s holdings, making the stock its 16th largest holding.

A number of other institutional investors have also recently bought and sold shares of UNH. Geode Capital Management LLC lifted its stake in UnitedHealth Group by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock valued at $10,068,869,000 after buying an additional 319,515 shares during the period. Capital International Investors raised its position in shares of UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock valued at $7,899,905,000 after acquiring an additional 906,365 shares during the period. Norges Bank acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $6,375,744,000. Franklin Resources Inc. raised its holdings in UnitedHealth Group by 10.7% in the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock worth $4,514,178,000 after purchasing an additional 861,854 shares during the period. Finally, Bank of New York Mellon Corp grew its holdings in shares of UnitedHealth Group by 0.5% in the 4th quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate’s stock valued at $4,012,218,000 after buying an additional 36,394 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $418.20 on Friday. The company has a market capitalization of $380.66 billion, a price-to-earnings ratio of 26.98, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52 week low of $412.02 and a 52 week high of $630.73. The company has a 50-day simple moving average of $503.28 and a 200 day simple moving average of $534.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the previous year, the business posted $6.91 earnings per share. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.01%. UnitedHealth Group’s payout ratio is presently 35.18%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research analyst reports. Argus cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Truist Financial dropped their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating on the stock in a report on Monday, April 21st. Erste Group Bank raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Wednesday, April 16th. Barclays reduced their target price on shares of UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating for the company in a research note on Monday, April 21st. Finally, Morgan Stanley cut their price target on UnitedHealth Group from $664.00 to $563.00 and set an “overweight” rating on the stock in a report on Tuesday, April 22nd. Three investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $603.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.